These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18600561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5-HT2C ligands: recent progress.
    Monck NJ, Kennett GA.
    Prog Med Chem; 2008; 46():281-390. PubMed ID: 18381128
    [No Abstract] [Full Text] [Related]

  • 3. Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
    Liu KK, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons C, Maurer TS, Marala R, Brown J, Kong JX, Lee E, Werner W, Wenzel Z, Vage C.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):266-71. PubMed ID: 19914063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.
    Ahmad S, Ngu K, Miller KJ, Wu G, Hung CP, Malmstrom S, Zhang G, O'Tanyi E, Keim WJ, Cullen MJ, Rohrbach KW, Thomas M, Ung T, Qu Q, Gan J, Narayanan R, Pelleymounter MA, Robl JA.
    Bioorg Med Chem Lett; 2010 Feb 01; 20(3):1128-33. PubMed ID: 20022752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H.
    Pharmacol Ther; 2008 Feb 01; 117(2):207-31. PubMed ID: 18068807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.
    Miller KJ.
    Mol Interv; 2005 Oct 01; 5(5):282-91. PubMed ID: 16249524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
    Andrews MD, Green MP, Allerton CM, Batchelor DV, Blagg J, Brown AD, Gordon DW, McMurray G, Millns DJ, Nichols CL, Watson L.
    Bioorg Med Chem Lett; 2009 Sep 15; 19(18):5346-50. PubMed ID: 19692241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
    Brennan PE, Whitlock GA, Ho DK, Conlon K, McMurray G.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):4999-5003. PubMed ID: 19646865
    [Abstract] [Full Text] [Related]

  • 18. Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists.
    Adams DR, Bentley JM, Benwell KR, Bickerdike MJ, Bodkin CD, Cliffe IA, Dourish CT, George AR, Kennett GA, Knight AR, Malcolm CS, Mansell HL, Misra A, Quirk K, Roffey JR, Vickers SP.
    Bioorg Med Chem Lett; 2006 Feb 01; 16(3):677-80. PubMed ID: 16257207
    [Abstract] [Full Text] [Related]

  • 19. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I.
    Eur J Pharmacol; 2008 Oct 10; 594(1-3):32-8. PubMed ID: 18703043
    [Abstract] [Full Text] [Related]

  • 20. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
    Allerton CM, Andrews MD, Blagg J, Ellis D, Evrard E, Green MP, Liu KK, McMurray G, Ralph M, Sanderson V, Ward R, Watson L.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5791-5. PubMed ID: 19716297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.